Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Mayo Clin Proc. 2017 Aug 25;92(9):1328–1340. doi: 10.1016/j.mayocp.2017.05.030

Table 1.

Characteristics of women with histories of normotensive and preeclamptic pregnancies

Variable Normotensive
(n=40)
Preeclampsia
(n=40)
P-value
Age at study consent 59.7±4.5 59.4±4.8 .78
Age at 1st live birth 24.3±3.4 24.2±3.7 .90
Anti-hypertensive medications 5 (13%) 23 (58%) <.001
Lipid lowering agents 5 (13%) 10 (25%) .15
Aspirin 6 (15%) 11 (28%) .17
Anti-inflammatory medications 20 (50%) 27 (68%) .11
Past or current hormone therapy 17 (43%) 17 (43%) 1.00
Tobacco Use: .21
. Never 21 (53%) 28 (70%)
. Past 15 (38%) 8 (20%)
. Current 4 (10%) 4 (10%)
Clinical parameters
Body mass index (kg/m2) 25.3 (23.1, 32.0) 29.8 (25.9, 33.7) .02
Waist circumference (cm) 85.3 (79.3, 99.6) 98.0 (88.3, 104.0) .009
Systolic blood pressure (mm Hg) 131.4±20.6 131.8±14.9 .91
Diastolic blood pressure (mm Hg) 75.8±10.7 78.2±9.6 .29
Current hypertension 8 (20%) 24 (60%) <.001
Diabetes mellitus 2 (5%) 4 (10%) .41
Gestational diabetes mellitus 2 (5%) 2 (5%) 1.00
Hyperlipidemia 29 (73%) 32 (80%) .43
Blood chemistry
Total cholesterol (mg/dL) 204.5 (182.0, 222.5) 189.5 (168.0, 215.0) .10
LDL Cholesterol (mg/dL) 123.0 (99.7, 136.4) 106.1 (87.9, 124.3) .09
HDL Cholesterol (mg/dL) 64.0 (50.5, 76.5) 54.5 (41.0, 69.5) .05
Triglycerides (mg/dL) 97.5 (72.0, 123.5) 108.0 (85.0, 163.0) .08
If Fasting glucose (mg/dL) 95.5 (91.0, 101.5) 98.0 (91.5, 109.5) .15
Insulin (μIU/mL) 4.6 (3.3, 6.0) 7.1 (4.7, 14.8) <.001
HOMA Insulin resistance (HOMA-IR) 1.1 (0.8, 1.5) 1.8 (1.1, 4.0) <.001

Continuous variables are reported as mean ± SD, median (IQR), or n (%)